Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV001191971 | SCV001359914 | likely benign | Cardiomyopathy | 2019-01-20 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001399196 | SCV001600981 | likely benign | Hypertrophic cardiomyopathy | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002427140 | SCV002726327 | likely benign | Cardiovascular phenotype | 2022-04-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |